Abstract:Forkhead box M1 (FOXM1), a member of the Fox family of transcriptional factors, is considered to be an independent predictor of poor survival in many solid cancers. However, the underlying mechanism is not yet clear. The aim of the present study was to investigate the clinical significance of the correlation between FOXM1 and epithelial-mesenchymal transition (EMT) in non-small cell lung carcinoma and the possible mechanism responsible for FOXMl-induced EMT and metastasis. In the present study, expression levels of FOXM1 and EMT indicator proteins were determined by tissue microarray (TMA) and immunohistochemical staining, western blotting and reverse transcription-PCR (RT-PCR). Other cellular and molecular approaches including gene transfection, small interfering RNA (siRNA), and migration and invasion assays were utilized. Our results demonstrated that FOXM1 overexpression was statistically significantly associated with a higher TNM stage (p=0.036), lymph node metastasis (p=0.009) and a positive smoking history of the patients (p=0.044). Additionally, high expression of FOXM1 correlated with loss of E-cadherin expression (p<0.001) and anomalous immunopositivity of Vimentin (p=0.002). Moreover, patient survival analysis demonstrated that high expression of FOXM1 (p=0.043) and the presence of lymph node metastasis (p=0.042) were independent prognostic factors for non-small cell lung cancer (NSCLC). Furthermore, various in vitro experiments indicated that overexpression or knockdown of FOXM1 expression altered EMT through activation or inhibition of the AKT/p70(S6K) signaling pathway. Collectively, the results suggest that FOXM1 may be used as a prognostic indicator for patients with NSCLC and promotes metastasis by inducing EMT of lung cancer cells through activation of the AKT/p70(S6K) pathway. Therefore, we suggest that FOXM1 may be a potential target for lung cancer therapy.

Forkhead Box Protein M1 Predicts Outcome in Human Osteosarcoma.

Correlation Between Expression of Forkhead Box M1 (FOXM1) and Clinicopathological Features and Prognosis in Patients with Non-Small Cell Lung Cancer (NSCLC)

Increased Expression of Forkhead Box M1 Protein is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma

Overexpression of Forkhead Box M1 Protein Associates with Aggressive Tumor Features and Poor Prognosis of Hepatocellular Carcinoma

Prognostic Value of FOXQ1 in Patients with Malignant Solid Tumors: a Meta-Analysis.

Forkhead box C1 is targeted by microRNA-133b and promotes cell proliferation and migration in osteosarcoma.

Identification of Tumorigenicity-Associated Genes in Osteosarcoma Cell Lines Based on Bioinformatic Analysis and Experimental Validation.

FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression

Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.

FoxM1: a Novel Tumor Biomarker of Lung Cancer.

Forkhead Box N1 is Possibly a Novel Biomarker and Prognostic Indicator for Patients with Squamous Cell Lung Carcinoma

Prognostic Significance of Phosphorylated FOXO1 Expression in Soft Tissue Sarcoma

Expression of High Mobility Group Box 1 Protein Predicts A Poorer Prognosis for Patients with Osteosarcoma

FOXM1 Expression Correlates with Tumor Invasion and a Poor Prognosis of Colorectal Cancer

Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.

Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma

Overexpression of Hypoxia-Inducible Factor-1 Alpha in Human Osteosarcoma: Correlation with Clinicopathological Parameters and Survival Outcome

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas

Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.

MUC1 Promotes Cancer Stemness and Predicts Poor Prognosis in Osteosarcoma.

Hypoxia-Inducible Factor-1 Expression Predicts Osteosarcoma Patients’ Survival: A Meta-Analysis